Found 2 hits for monomerid = 50377900 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Gonadotropin-releasing hormone receptor
(Homo sapiens (Human)) | BDBM50377900
(CHEMBL259906)Show SMILES COc1cccc(c1F)-c1c(C)n(Cc2c(F)cccc2C(F)(F)F)c(=O)n(C[C@H](C)NC2CCCC2)c1=O |wD:29.31,(1.43,-22.95,;.1,-23.72,;.1,-25.26,;1.44,-26.03,;1.44,-27.57,;.11,-28.34,;-1.22,-27.56,;-1.23,-26.03,;-2.56,-25.26,;-2.55,-28.33,;-2.56,-29.87,;-1.22,-30.64,;-3.89,-30.64,;-3.9,-32.18,;-4.72,-33.49,;-6.25,-33.44,;-6.99,-32.09,;-7.06,-34.76,;-6.32,-36.11,;-4.77,-36.15,;-3.98,-34.83,;-2.44,-34.86,;-.9,-34.86,;-2.45,-36.4,;-2.42,-33.32,;-5.22,-29.87,;-6.56,-30.64,;-5.22,-28.32,;-6.55,-27.56,;-7.88,-28.33,;-7.88,-29.87,;-9.22,-27.56,;-9.22,-26.02,;-7.97,-25.11,;-8.45,-23.64,;-9.99,-23.65,;-10.47,-25.11,;-3.89,-27.55,;-3.89,-26.01,)| Show InChI InChI=1S/C28H30F5N3O3/c1-16(34-18-8-4-5-9-18)14-36-26(37)24(19-10-6-13-23(39-3)25(19)30)17(2)35(27(36)38)15-20-21(28(31,32)33)11-7-12-22(20)29/h6-7,10-13,16,18,34H,4-5,8-9,14-15H2,1-3H3/t16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.610 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Neurocrine Biosciences, Inc.
Curated by ChEMBL
| Assay Description Binding affinity to human GnRHR |
Bioorg Med Chem Lett 18: 3344-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.04.029 BindingDB Entry DOI: 10.7270/Q2CJ8FBF |
More data for this Ligand-Target Pair | |
Gonadotropin-releasing hormone receptor
(Homo sapiens (Human)) | BDBM50377900
(CHEMBL259906)Show SMILES COc1cccc(c1F)-c1c(C)n(Cc2c(F)cccc2C(F)(F)F)c(=O)n(C[C@H](C)NC2CCCC2)c1=O |wD:29.31,(1.43,-22.95,;.1,-23.72,;.1,-25.26,;1.44,-26.03,;1.44,-27.57,;.11,-28.34,;-1.22,-27.56,;-1.23,-26.03,;-2.56,-25.26,;-2.55,-28.33,;-2.56,-29.87,;-1.22,-30.64,;-3.89,-30.64,;-3.9,-32.18,;-4.72,-33.49,;-6.25,-33.44,;-6.99,-32.09,;-7.06,-34.76,;-6.32,-36.11,;-4.77,-36.15,;-3.98,-34.83,;-2.44,-34.86,;-.9,-34.86,;-2.45,-36.4,;-2.42,-33.32,;-5.22,-29.87,;-6.56,-30.64,;-5.22,-28.32,;-6.55,-27.56,;-7.88,-28.33,;-7.88,-29.87,;-9.22,-27.56,;-9.22,-26.02,;-7.97,-25.11,;-8.45,-23.64,;-9.99,-23.65,;-10.47,-25.11,;-3.89,-27.55,;-3.89,-26.01,)| Show InChI InChI=1S/C28H30F5N3O3/c1-16(34-18-8-4-5-9-18)14-36-26(37)24(19-10-6-13-23(39-3)25(19)30)17(2)35(27(36)38)15-20-21(28(31,32)33)11-7-12-22(20)29/h6-7,10-13,16,18,34H,4-5,8-9,14-15H2,1-3H3/t16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Neurocrine Biosciences, Inc.
Curated by ChEMBL
| Assay Description Antagonist activity at human GnRHR assessed as inhibition of calcium flux by IP3 assay |
Bioorg Med Chem Lett 18: 3344-9 (2008)
Article DOI: 10.1016/j.bmcl.2008.04.029 BindingDB Entry DOI: 10.7270/Q2CJ8FBF |
More data for this Ligand-Target Pair | |